Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Medicare covers lupus treatment in different ways depending on your age and how the condition affects you. Read more.

as well as trials in cutaneous lupus erythematosus and myositis. Brian Hilberdink, Boehringer Ingelheim's new Head of US Human Pharma, fielded questions on a variety of hot topics from the Reuters ...

Systemic Lupus Erythematosus (about 70% of cases are systemic); Discoid Lupus Cutaneous, which is limited to the skin; and Drug Induced Lupus, which occurs most commonly with drugs used to treat ...

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. | The drug discovery pact between Charles River Laboratories, Valo Health and ...

Systemic lupus erythematosus (SLE) is the most common type of lupus. According to 2019 criteria from the ACR and EULAR, you must have antinuclear antibodies to receive an SLE diagnosis.

Lupus-related antibody shows promise in enhancing cancer treatment efficacy. ScienceDaily . Retrieved March 26, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250325141527.htm ...